Canntab Therapeutics (QB) Stock Price - CTABF

0.351
0.00 (0.00%)
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Small Cap Pro
Monthly Subscription
for only
$49.05
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
VAT not included
Company Name Stock Ticker Symbol Market Type
Canntab Therapeutics Ltd (QB) CTABF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 0.351 0.00 0.00 0.00 0.351 19:00:00
Bid Price Ask Price Spread Spread % News
0.2974 0.4046 0.1072 26.5% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

Canntab Therapeutics (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 8.88M 25.31M $ -2.41M - - 16.86M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
1.13k $ - 0.00% - -

more financials information »

Canntab Therapeutics (QB) News

Loading Messages....

Latest CTABF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CTABF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.32910.3510.32910.3518,0450.02196.65%
1 Month0.36540.36550.32910.34869843,715-0.0144-3.94%
3 Months0.3030.42790.30280.35370743,6620.04815.84%
6 Months0.43460.500.30280.38063943,225-0.0836-19.24%
1 Year0.62720.6495750.30280.46094182,805-0.2762-44.04%
3 Years0.03221.640.01660.53906583,7240.3188990.06%
5 Years0.03221.640.01660.53906583,7240.3188990.06%

Canntab Therapeutics (QB) Description

Canntab Therapeutics is a Canadian cannabis oral dosage formulation company based in Markham, Ont., engaged in the research and development of advanced pharmaceutical-grade formulations of cannabinoids. Canntab has developed patent-pending technology to deliver standardized medical cannabis extract from selective strains in a variety of extended-release/sustained-release pharmaceutical dosages for therapeutic use. In doing so, Canntab has developed a suite of precision oral dose products that are unavailable elsewhere in the marketplace. Canntab's primary focus is on providing cannabis-based products to medical professionals that can be used to deliver therapeutic treatments to their patients. Canntab trades on the Canadian Securities Exchange under the symbol PILL, on the OTCQB Venture Market under the symbol CTABF, and on the Frankfurt Stock Exchange under the symbol TBF1.


Your Recent History
USOTC
CTABF
Canntab Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.